Compare BioNano Genomics Inc (BNGO) vs KraneShares Electric Vehicles and Future Mobility (KARS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs KraneShares Electric Vehicles and Future Mobility — how do they compare? BioNano Genomics Inc trades at $1.18 (market cap $13.66M), while KraneShares Electric Vehicles and Future Mobility trades at $30.99. The key difference: KraneShares Electric Vehicles and Future Mobility is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | KARS | |
|---|---|---|
Market Cap | $13.66M | — |
Sector | Health | Sector/Thematic |
52-Week High | $4.92 | $38.01 |
52-Week Low | $1.06 | $25.59 |
Enterprise Value | $16.26M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.195, up 3.02% today, with a bullish technical signal from moving averages but a neutral oscillator stance. The company shows improving financial trends, with net losses narrowing to -$26.40M in 2025 from -$232M in 2023, and recent earnings beats. Revenue stabilized around $29M, while cash flow trends indicate reduced operational cash burn. Analyst sentiment is positive, with 57% buy ratings.
The outlook for BNGO hinges on sustaining revenue growth and achieving profitability, supported by strategic hires and debt retirement. Key risks include persistent negative margins and high cash burn. With a low P/S of 0.31, the stock offers value if execution improves, but investors face volatility from operational challenges and competitive pressures.
KARS trades at $30.95, down 0.55% today, with a bullish technical signal driven by moving averages and oscillators, though the RSI_6 at 85.22 suggests overbought conditions. Support lies near $30, resistance at $31. Recent news highlights strong global EV sales growth, particularly in Europe and China, driven by high fuel prices and policy support, though U.S. adoption lags.
The outlook for KARS is supported by accelerating EV adoption globally, but risks include U.S. market hesitation, competitive pressures from Chinese automakers, and potential volatility from geopolitical events. Analyst sentiment is mixed, with technical indicators bullish but valuation metrics unavailable, requiring close monitoring of upcoming financial results for clarity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About KraneShares Electric Vehicles and Future Mobility
KARS invests in the global electric vehicle ecosystem and future mobility. It tracks the Bloomberg Electric Vehicles Index, providing exposure to EV manufacturers, battery technology, and lithium miners like Tesla, BYD, and Albemarle.
Read more on KARS →
